Core Viewpoint - ITT has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based solely on changes in a company's earnings picture, which is a critical factor for stock price movements [2][4]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling actions that affect stock prices [4]. ITT's Earnings Outlook - For the fiscal year ending December 2025, ITT is expected to earn $6.65 per share, consistent with the previous year's reported figure, while the Zacks Consensus Estimate has increased by 2.6% over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - ITT's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10].

Core Viewpoint - Research Solutions Inc. (RSSS) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the correlation between changes in earnings estimates and stock price movements, suggesting that upward revisions can lead to increased buying pressure and higher stock prices [4][5]. - Research Solutions is projected to earn $0.14 per share for the fiscal year ending June 2026, with a year-over-year change of zero, but the Zacks Consensus Estimate has increased by 16.7% over the past three months [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions, which positions Research Solutions favorably for potential market-beating returns [9][10].

TTM Technologies (TTMI) closed the last trading session at $58.45, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $76 indicates a 30% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $3.16. While the lowest estimate of $72.00 indicates a 23.2% increase from the current price level, the most optimistic analyst expe ...

Core Viewpoint - Tango Therapeutics, Inc. (TNGX) has seen an 18.2% increase in share price over the past four weeks, closing at $8.9, with a potential upside of 46.1% based on Wall Street analysts' mean price target of $13 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $1.31, indicating variability among analysts [2]. - The lowest price target is $11.00, suggesting a 23.6% increase, while the highest target is $15.00, indicating a potential surge of 68.5% [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about TNGX's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher [11]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 15.1%, with six estimates moving higher and no negative revisions [12]. - TNGX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the stock's potential gain, the implied direction of price movement appears to be a useful guide [14].

Core Viewpoint - Enanta Pharmaceuticals (ENTA) shares have increased by 13.7% in the past four weeks, closing at $12.13, with a potential upside of 44.9% based on Wall Street analysts' mean price target of $17.57 [1][4]. Price Targets and Analyst Estimates - The mean price target is derived from seven short-term estimates, with a standard deviation of $5.44, indicating variability among analysts [2]. - The lowest estimate is $9.00, suggesting a 25.8% decline from the current price, while the highest estimate is $25.00, indicating a potential surge of 106.1% [2]. - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Sentiment - Analysts are optimistic about ENTA's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which have increased by 22.4% over the past month [11][12]. - The Zacks Consensus Estimate for the current year reflects this optimism, with no negative revisions reported [12]. - ENTA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Caution on Price Targets - While consensus price targets are a common metric for investors, relying solely on them for investment decisions may not be prudent due to historical inaccuracies [3][10]. - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated estimates [8].

Group 1 - Sandisk Corporation (SNDK) shares have increased by 17.3% in the past four weeks, closing at $195.96, with a mean price target of $262.54 indicating a potential upside of 34% [1] - The average of 13 short-term price targets ranges from a low of $220.00 to a high of $300.00, with a standard deviation of $23.85, suggesting a potential increase of 12.3% to 53.1% from the current price [2] - Analysts show strong agreement on SNDK's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 75.9% over the past month, with five estimates increasing and no negative revisions [12] - SNDK holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement, which appears to be a good guide [14]

Group 1 - O-I Glass (OI) closed at $12.7, with a 3.3% gain over the past four weeks, and a mean price target of $16.56 suggests a 30.4% upside potential [1] - The average price targets range from $13.00 to $19.00, with a standard deviation of $2.07, indicating variability among analysts' estimates [2] - Analysts have shown increasing optimism about OI's earnings prospects, with a strong agreement in revising EPS estimates higher, correlating with potential stock price movements [11][12] Group 2 - The Zacks Consensus Estimate for the current year has increased by 8.3% over the past month, with four estimates going higher and no negative revisions [12] - OI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - ON Holding (ONON) shows potential for significant upside, with a mean price target of $60.68 indicating a 40.1% increase from the current price of $43.3 [1] Price Targets - The average price target consists of 22 estimates, ranging from a low of $30.00 to a high of $85.00, with a standard deviation of $10.3, indicating variability among analysts [2] - The lowest estimate suggests a decline of 30.7%, while the highest indicates a potential upside of 96.3% [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual price movements [7][10] Analyst Sentiment - There is strong agreement among analysts regarding ONON's ability to report better earnings, which supports the expectation of an upside [4][11] - Over the past 30 days, five earnings estimates have been revised upward, leading to a Zacks Consensus Estimate increase of 89.2% [12] Zacks Rank - ONON holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Conclusion - While the consensus price target may not be a reliable indicator of the extent of potential gains, the direction it implies appears to be a useful guide for further research [14]

Core Viewpoint - El Pollo Loco Holdings (LOCO) has seen a 7.1% increase in share price over the past four weeks, closing at $10.24, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $13.67, representing a 33.5% upside [1][2]. Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $3.79, where the lowest estimate of $11.00 indicates a 7.4% increase, and the highest estimate of $18.00 suggests a 75.8% increase [2]. - A low standard deviation among price targets indicates a strong agreement among analysts regarding the stock's price movement, which can be a useful starting point for further research [9]. Earnings Estimates and Analyst Sentiment - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases, as indicated by a 6.7% increase in the Zacks Consensus Estimate over the past month [11][12]. - LOCO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside [13]. Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, the implied direction of price movement appears to be a valid guide for investors [14].

Core Viewpoint - Analyst recommendations play a significant role in influencing stock prices, but their reliability is questionable due to potential biases from brokerage firms [1][5][10]. Brokerage Recommendations - Onto Innovation (ONTO) has an average brokerage recommendation (ABR) of 1.78, indicating a consensus between Strong Buy and Buy, with 55.6% of recommendations being Strong Buy and 11.1% being Buy [2][5]. - The ABR is based on recommendations from nine brokerage firms, with five Strong Buy and one Buy [2]. Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations have limited success in guiding investors towards stocks with the highest price increase potential [5][10]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, often issuing five Strong Buy recommendations for every Strong Sell [6][10]. Zacks Rank as an Alternative - Zacks Rank categorizes stocks into five groups based on earnings estimate revisions, which have shown a strong correlation with near-term stock price movements [8][11]. - The Zacks Rank is distinct from ABR, as it is a quantitative model based on earnings estimates, while ABR is derived from brokerage recommendations [9][13]. Current Earnings Estimates for Onto Innovation - The Zacks Consensus Estimate for Onto Innovation has increased by 1.1% over the past month to $4.94, reflecting growing optimism among analysts regarding the company's earnings prospects [14]. - The recent change in consensus estimates has contributed to a Zacks Rank of 2 (Buy) for Onto Innovation, suggesting a positive outlook for the stock [15].